Increased bone density and resistance to ovariectomy-induced bone loss in FoxP3-transgenic mice based on impaired osteoclast differentiation

Arthritis and Rheumatism

Volumn 62, Issue 8, 2010, Pages 2328-2338

  Zaiss, Mario M ^a   Sarter, Kerstin ^a   Hess, Andreas ^a   Engelke, Klaus ^a   Böhm, Christina ^a   Nimmerjahn, Falk ^a   Voll, Reinhard ^a   Schett, Georg ^a   David, Jean Pierre ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RAG1 PROTEIN; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE MASS; BONE REMODELING; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HOMEOSTASIS; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MEDICAL PARAMETERS; MONOCYTE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLASTOGENESIS; OSTEOLYSIS; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; WILD TYPE;

ANIMALS; BONE AND BONES; BONE DENSITY; BONE RESORPTION; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; OSTEOCLASTS; OVARIECTOMY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTE SUBSETS;

EID: 77955373402     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27535     Document Type: Article

References (41)

1. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A 1999;96:3540-5.
2. Teitelbaum SL, Ross FP. Genetic regulation of osteoclast development and function. Nat Rev Genet 2003;4:638-49.
3. Bruzzaniti A, Baron R. Molecular regulation of osteoclast activity. Rev Endocr Metab Disord 2006;7:123-39.
4. Komori T. Regulation of osteoblast differentiation by transcription factors. J Cell Biochem 2006;99:1233-9.
5. Walsh MC, Kim N, Kadono Y, Rho J, Lee SY, Lorenzo J, et al. Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol 2006;24:33-63.
6. Horowitz MC, Bothwell AL, Hesslein DG, Pflugh DL, Schatz DG. B cells and osteoblast and osteoclast development. Immunol Rev 2005;208:141-53.
7. Wong BR, Josien R, Lee SY, Sauter B, Li HL, Steinman RM, et al. TRANCE (tumor necrosis factor [TNF]-related activationinduced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 1997;186:2075-80. (Pubitemid 28013694)
8. Lee SK, Kadono Y, Okada F, Jacquin C, Koczon-Jaremko B, Gronowicz G, et al. T lymphocyte-deficient mice lose trabecular bone mass with ovariectomy. J Bone Miner Res 2006;21:1704-12. (Pubitemid 46141225)
9. Weitzmann MN, Pacifici R. The role of T lymphocytes in bone metabolism. Immunol Rev 2005;208:154-68.
10. Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med 2007;13:156-63. (Pubitemid 46245765)
11. Goldring SR, Goldring MB. Eating bone or adding it: the Wnt pathway decides. Nat Med 2007;13:133-4.
12. Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature 2000;408:600-5.
13. Gao Y, Grassi F, Ryan MR, Terauchi M, Page K, Yang X, et al. IFN-γ stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest 2007;117:122-32. (Pubitemid 46048459)
14. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 2006;203:2673-82. (Pubitemid 44833343)
15. Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol 2006;24:209-26.
16. + regulatory T cells. Immunol Rev 2006;212:60-73.
17. Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 2005;6:331-7.
18. Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003;3:253-7.
19. Godfrey V, Wilkinson JE, Russell LB. X-linked lymphoreticular disease in the scurfy (sf) mutant. Am J Pathol 1991;138:1379-87.
20. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001;27:68-73. (Pubitemid 32044521)
21. + T regulatory cells. Nat Immunol 2003;4: 337-42.
22. + regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc Natl Acad Sci U S A 2002;99:8213-8.
23. Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G, Ye J, et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004;199:1455-65.
24. + regulatory T cells. J Immunol 2003;170:3939-43.
25. Shevach EM. Regulatory T cells in autoimmunity. Annu Rev Immunol 2000;18:423-49.
26. + regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005;6:345-52.
27. Kim YG, Lee CK, Nah SS, Mun SH, Yoo B, Moon HB. Human CD4+CD25+ regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells. Biochem Biophys Res Commun 2007;357:1046-52. (Pubitemid 46693677)
28. Zaiss MM, Axmann R, Zwerina J, Polzer K, Guckel E, Skapenko A, et al. Treg cells suppress osteoclast formation: a new link between the immune system and bone. Arthritis Rheum 2007;56:4104-12. (Pubitemid 350262338)
29. Wachsmuth L, Engelke K. High-resolution imaging of osteoarthritis using microcomputed tomography. Methods Mol Med 2004;101:231-48.
30. Bohm C, Hayer S, Kilian A, Zaiss MM, Finger S, Hess A, et al. The α-isoform of p38 MAPK specifically regulates arthritic bone loss. J Immunol 2009;183:5938-47.
31. Zwerina J, Hayer S, Tohidast-Akrad M, Bergmeister H, Redlich K, Feige U, et al. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor - induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction. Arthritis Rheum 2004;50:277-90. (Pubitemid 38084313)
32. Axmann R, Herman S, Zaiss MM, Franz S, Polzer K, Zwerina J, et al. CTLA-4 directly inhibits osteoclast formation. Ann Rheum Dis 2008;67:1603-9.
33. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999;402:304-9.
34. David JP. Osteoimmunology: a view from the bone. Adv Immunol 2007;95:149-65.
35. Alnaeeli M, Park J, Mahamed D, Penninger JM, Teng YT. Dendritic cells at the osteo-immune interface: implications for inflammation-induced bone loss. J Bone Miner Res 2007;22:775-80. (Pubitemid 351339736)
36. Roux S, Lambert-Comeau P, Saint-Pierre C, Lepine M, Sawan B, Parent JL. Death receptors, Fas and TRAIL receptors, are involved in human osteoclast apoptosis. Biochem Biophys Res Commun 2005;333:42-50. (Pubitemid 40813444)
37. Zauli G, Rimondi E, Nicolin V, Melloni E, Celeghini C, Secchiero P. TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF. Blood 2004;104:2044-50. (Pubitemid 39297855)
38. Zauli G, Rimondi E, Stea S, Baruffaldi F, Stebel M, Zerbinati C, et al. TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27Kip1 accumulation in pre-osteoclast precursors. J Cell Physiol 2008;214:117-25. (Pubitemid 350220065)
39. Key LL Jr, Rodriguiz RM, Willi SM, Wright NM, Hatcher HC, Eyre DR, et al. Long-term treatment of osteopetrosis with recombinant human interferon γ. N Engl J Med 1995;332:1594-9.
40. Morgan ME, Flierman R, van Duivenvoorde LM, Witteveen HJ, van Ewijk W, van Laar JM, et al. Effective treatment of collageninduced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum 2005;52:2212-21. (Pubitemid 40994344)
41. Nguyen LT, Jacobs J, Mathis D, Benoist C. Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum 2007;56:509-20. (Pubitemid 46271977)